Polarean Imaging (PLLWF) Stock Price, News & Analysis

Company Overview

Polarean Imaging is a clinical-stage medical imaging company focused on the development and commercialisation of hyperpolarized xenon gas technology to enhance pulmonary MRI. By using specialized spin-exchange optical pumping equipment to polarize xenon-129, the company delivers an inhalable contrast agent that improves visualization of lung ventilation and gas exchange for non-invasive respiratory assessments.

The company’s core product suite includes hyperpolarizer units designed for integration with existing MRI platforms and single-dose xenon contrast kits. Polarean has secured Investigational New Drug (IND) authorization from the U.S. Food and Drug Administration and a CE Mark in Europe, enabling multiple clinical trials in asthma, chronic obstructive pulmonary disease and pulmonary fibrosis.

Established with roots in academic research, Polarean Imaging serves hospitals, academic medical centres and research institutions across North America and Europe. Its R&D and manufacturing facilities support ongoing clinical studies and lay the groundwork for future commercial deployment of its imaging systems.

Led by an experienced management team with backgrounds in medical device innovation, pulmonary medicine and regulatory affairs, Polarean Imaging is advancing toward full regulatory approvals. The company’s mission is to equip clinicians with precise functional lung imaging tools that enhance diagnosis, treatment planning and monitoring of respiratory diseases.

Key Stats

• Today's Range: $0.0066 to $0.0066
• 50-Day Range: $0.0066 to $0.0066
• 52-Week Range: $0.0010 to $0.0067
• Volume: N/A
• Average Volume: 32,143 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/17/2026
• Next Earnings (Estimated): 8/27/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PLLWF
• CIK: N/A
• Web: www.polarean.com
• Phone: 919 206 7900
• Fax: N/A
• Employees: 28
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A